Folic acid prevents the initial occurrence of sporadic colorectal adenoma in Chinese older than 50 years of age: A randomized clinical trial

Cancer Prevention Research

Volumn 6, Issue 7, 2013, Pages 744-752

  Gao, Qin Yan ^a   Chen, Hui Min ^a   Chen, Ying Xuan ^a   Wang, Ying Chao ^a   Wang, Zheng Hua ^a   Tang, Jie Ting ^a   Ge, Zhi Zheng ^a   Chen, Xiao Yu ^a   Sheng, Jian Qiu ^d   Fang, Dian Chun ^b   Yu, Cheng Gong ^e   Zheng, Ping ^c   Fang, Jing Yuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Department of Oral and Maxillofacial Surgery   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d General Military Hospital   (China)

^e NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; VITAMIN B COMPLEX;

ADULT; ALLERGIC REACTION; ARTICLE; CANCER RISK; CHINESE; COLONOSCOPY; COLORECTAL ADENOMA; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG BLOOD LEVEL; FEMALE; FOLIC ACID BLOOD LEVEL; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; ADENOMA; CASE CONTROL STUDY; CLINICAL TRIAL; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; DIET SUPPLEMENTATION; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR;

ADENOMA; CASE-CONTROL STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; VITAMIN B COMPLEX;

EID: 84880060643     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-13-0013     Document Type: Article

References (44)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.
2. Tsoi KK, Ng SS, Leung MC, Sung JJ. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia. Aliment Pharmacol Ther 2008;28:353-63.
3. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329:1977-81.
4. Cotton S, Sharp L, Little J. The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia. Crit Rev Oncog 1996;7:293-342.
5. Manzano A, Pérez-Segura P. Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention? Scientific World Journal. 2012;2012:327341. doi: 10.1100/2012/327341. Epub 2012 Apr 29.
6. Marshall JR. Prevention of colorectal cancer: diet, chemoprevention, and lifestyle. Gastroenterol Clin North Am 2008;37:73-82.
7. Strul H, Kariv R, Leshno M, Halak A, Jakubowicz M, Santo M, et al. The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40-80 years. Am J Gastroenterol 2006;101: 255-62.
8. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000;343:162-8.
9. Sung JJ, Lau JY, Goh KL, Leung WK, Asia Pacific Working Group on Colorectal Cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 2005;6:871-6.
10. Leung WK, Ho KY, Kim WH, Lau JY, Ong E, Hilmi I, et al. Colorectal neoplasia in Asia: a multicenter colonoscopy survey in symptomatic patients. Gastrointest Endosc 2006;64:751-9.
11. Chen HM, Weng YR, Jiang B, Sheng JQ, Zheng P, Yu CG, et al. Epidemiological study of colorectal adenoma and cancer in symptomatic patients in China between 1990 and 2009. J Dig Dis 2011;12:371-8.
12. Phillips KA, Liang SY, Ladabaum U, Haas J, Kerlikowske K, Lieberman D, et al. Trends in colonoscopy for colorectal cancer screening. Med Care 2007;45:160-7.
13. Rundle AG, Lebwohl B, Vogel R, Levine S, Neugut AI. Colonoscopic screening in average-risk individuals ages 40 to 49 vs 50 to 59 years. Gastroenterology 2008;134:1311-5.
14. Martinez ME, Baron JA, Lieberman DA, Schatzkin A, Lanza E, Winawer SJ, et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 2009;136: 832-41.
15. Gao QY, Chen HM, Sheng JQ, Zheng P, Yu CG, Jiang B, et al. The first year follow-up after colorectal adenoma polypectomy is important: a multiple-center study in symptomatic hospital-based individuals in China. Front Med China 2010;4:436-42.
16. Gao F, Liao C, Liu L, Tan A, Cao Y, Mo Z. The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials. Colorectal Dis 2009;11:893-901.
17. Dubse C, Rostom A, Lewin G, Tsertsvadze A, Barrowman N, Code C, et al. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 2007;146:365-75.
18. Wu K, Platz EA, Willett WC, Fuchs CS, Selhub J, Rosner BA, et al. A randomized trial on folic acid SUPPL.ementation and risk of recurrent colorectal adenoma. Am J Clin Nutr 2009;90:1623-31.
19. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007;297:2351-9.
20. Bresalier RS. Chemoprevention of colorectal cancer: why all the confusion? Curr Opin Gastroenterol 2008;24:48-50.
21. Ulrich CM, Potter JD. Folate and cancer-Timing is everything. JAMA 2007;297:2408-9.
22. Jaszewski R, Misra S, Tobi M, Ullah N, Naumoff JA, Kucuk O, et al. Folic acid SUPPL.ementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial. World J Gastroenterol 2008;14: 4492-8.
23. Lieberman DA, Prindiville S, Weiss DG, Willett W. VA Cooperative Study Group 380. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 2003; 290:2959-67.
24. Dodd LE, PepeMS. Partial AUC estimation and regression. Biometrics 2003;59:614-23. Folic Acid Prevents the Initial Occurrence of Colorectal Adenoma in Age >50 Years www.aacrjournals.org Cancer Prev Res; 6(7) July 2013 751.
25. Kennedy DA, Stern SJ, Moretti M, Matok I, Sarkar M, Nickel C, et al. Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol 2011;35:2-10.
26. de Vogel S, Dindore V, van Engeland M, Goldbohm RA, van den Brandt PA, Weijenberg MP. Dietary folate, methionine, riboflavin, and vitamin B-6 and risk of sporadic colorectal cancer. J Nutr 2008;138:2372-8.
27. Du W, Li WY, Lu R, Fang JY. Folate and fiber in the prevention of colorectal cancer: between shadows and the light. World J Gastroenterol 2010;16:921-6.
28. Lamprecht SA, Lipkin M. Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer 2003;3:601-14.
29. Lin YW, Wang JL, Chen HM, Zhang YJ, Lu R, Ren LL, et al. Folic Acid SUPPL.ementary reduce the incidence of adenocarcinoma in a mouse model of colorectal cancer: microarray gene expression profile. J Exp Clin Cancer Res 2011;30:116.
30. Martínez ME, Giovannucci E, Jiang R, Henning SM, Jacobs ET, Thompson P, et al. Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence. Int J Cancer 2006;119:1440-6.
31. Kim YI. Role of folate in colon cancer development and progression. J Nutr 2003;133:3731S-9S.
32. Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G, et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 2007;16:1325-9.
33. Selhub J, Bagley LC, Miller J, Rosenberg IH.Bvitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr 2000;71:614S-620S.
34. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B- 12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 2007;85:193-200.
35. Tettamanti M, Garr MT, Nobili A, Riva E, Lucca U. Low folate and the risk of cognitive and functional deficits in the very old: the Monzino 80- plus study. J Am Coll Nutr 2006;25:502-8.
36. Yan J, Wang W, Gregory JF III, Malysheva O, Brenna JT, Stabler SP, et al. MTHFR C677T genotype influences the isotopic enrichment of one-carbon metabolites in folate-compromised men consuming d9- choline. Am J Clin Nutr 2011;93:348-55.
37. Gupta SK, Kotwal J, Kotwal A, Dhall A, Garg S. Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians. Indian J Med Res 2012;135: 506-12.
38. Fletcher O, Kessling AM. MTHFR association with arteriosclerotic vascular disease? Hum Genet 1998;103:11-21.
39. Nilsson TK, Laanpere M, Altmae S, Serra-Majem L, Salumets A. A folate receptor alpha double-mutated haplotype 1816delC-1841A is distributed throughout Eurasia and associated with lower erythrocyte folate levels. Mol Biol Rep 2012;39:4471-8.
40. Bressler B, Lo C, Amar J, Whittaker S, Chaun H, Halparin L, et al. Prospective evaluation of screening colonoscopy: who is being screened? Gastrointest Endosc 2004;60:921-6.
41. Imperiale TF, Glowinski EA, Lin-Cooper C, Larkin GN, Rogge JD, Ransohoff DF. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med 2008;359:1218-24.
42. Leufkens AM, van Oijen MG, Vleggaar FP, Siersema PD. Factors influencing the miss rate of polyps in a back-to-back colonoscopy study. Endoscopy 2012;44:470-5.
43. Leung WK, Lau JY, Suen BY, Wong GL, Chow DK, Lai LH, et al. Repeat-screening colonoscopy 5 years after normal baseline-screening colonoscopy in average-risk Chinese: a prospective study. Am J Gastroenterol 2009;104:2028-34.
44. Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 2006;355:2533-41. Gao et al.